Cargando…
FFF-based high-throughput sequence shortlisting to support the development of aptamer-based analytical strategies
Aptamers are biomimetic receptors that are increasingly exploited for the development of optical and electrochemical aptasensors. They are selected in vitro by the SELEX (Systematic Evolution of Ligands by Exponential Enrichment) procedure, but although they are promising recognition elements, for t...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242963/ https://www.ncbi.nlm.nih.gov/pubmed/35182166 http://dx.doi.org/10.1007/s00216-022-03971-2 |
_version_ | 1784738185584050176 |
---|---|
author | Marassi, Valentina Mattarozzi, Monica Toma, Lorenzo Giordani, Stefano Ronda, Luca Roda, Barbara Zattoni, Andrea Reschiglian, Pierluigi Careri, Maria |
author_facet | Marassi, Valentina Mattarozzi, Monica Toma, Lorenzo Giordani, Stefano Ronda, Luca Roda, Barbara Zattoni, Andrea Reschiglian, Pierluigi Careri, Maria |
author_sort | Marassi, Valentina |
collection | PubMed |
description | Aptamers are biomimetic receptors that are increasingly exploited for the development of optical and electrochemical aptasensors. They are selected in vitro by the SELEX (Systematic Evolution of Ligands by Exponential Enrichment) procedure, but although they are promising recognition elements, for their reliable applicability for analytical purposes, one cannot ignore sample components that cause matrix effects. This particularly applies when different SELEX-selected aptamers and related truncated sequences are available for a certain target, and the choice of the aptamer should be driven by the specific downstream application. In this context, the present work aimed at investigating the potentialities of asymmetrical flow field-flow fractionation (AF4) with UV detection for the development of a screening method of a large number of anti-lysozyme aptamers towards lysozyme, including randomized sequences and an interfering agent (serum albumin). The possibility to work in native conditions and selectively monitor the evolution of untagged aptamer signal as a result of aptamer-protein binding makes the devised method effective as a strategy for shortlisting the most promising aptamers both in terms of affinity and in terms of selectivity, to support subsequent development of aptamer-based analytical devices. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00216-022-03971-2. |
format | Online Article Text |
id | pubmed-9242963 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-92429632022-07-01 FFF-based high-throughput sequence shortlisting to support the development of aptamer-based analytical strategies Marassi, Valentina Mattarozzi, Monica Toma, Lorenzo Giordani, Stefano Ronda, Luca Roda, Barbara Zattoni, Andrea Reschiglian, Pierluigi Careri, Maria Anal Bioanal Chem Research Paper Aptamers are biomimetic receptors that are increasingly exploited for the development of optical and electrochemical aptasensors. They are selected in vitro by the SELEX (Systematic Evolution of Ligands by Exponential Enrichment) procedure, but although they are promising recognition elements, for their reliable applicability for analytical purposes, one cannot ignore sample components that cause matrix effects. This particularly applies when different SELEX-selected aptamers and related truncated sequences are available for a certain target, and the choice of the aptamer should be driven by the specific downstream application. In this context, the present work aimed at investigating the potentialities of asymmetrical flow field-flow fractionation (AF4) with UV detection for the development of a screening method of a large number of anti-lysozyme aptamers towards lysozyme, including randomized sequences and an interfering agent (serum albumin). The possibility to work in native conditions and selectively monitor the evolution of untagged aptamer signal as a result of aptamer-protein binding makes the devised method effective as a strategy for shortlisting the most promising aptamers both in terms of affinity and in terms of selectivity, to support subsequent development of aptamer-based analytical devices. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00216-022-03971-2. Springer Berlin Heidelberg 2022-02-18 2022 /pmc/articles/PMC9242963/ /pubmed/35182166 http://dx.doi.org/10.1007/s00216-022-03971-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Paper Marassi, Valentina Mattarozzi, Monica Toma, Lorenzo Giordani, Stefano Ronda, Luca Roda, Barbara Zattoni, Andrea Reschiglian, Pierluigi Careri, Maria FFF-based high-throughput sequence shortlisting to support the development of aptamer-based analytical strategies |
title | FFF-based high-throughput sequence shortlisting to support the development of aptamer-based analytical strategies |
title_full | FFF-based high-throughput sequence shortlisting to support the development of aptamer-based analytical strategies |
title_fullStr | FFF-based high-throughput sequence shortlisting to support the development of aptamer-based analytical strategies |
title_full_unstemmed | FFF-based high-throughput sequence shortlisting to support the development of aptamer-based analytical strategies |
title_short | FFF-based high-throughput sequence shortlisting to support the development of aptamer-based analytical strategies |
title_sort | fff-based high-throughput sequence shortlisting to support the development of aptamer-based analytical strategies |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242963/ https://www.ncbi.nlm.nih.gov/pubmed/35182166 http://dx.doi.org/10.1007/s00216-022-03971-2 |
work_keys_str_mv | AT marassivalentina fffbasedhighthroughputsequenceshortlistingtosupportthedevelopmentofaptamerbasedanalyticalstrategies AT mattarozzimonica fffbasedhighthroughputsequenceshortlistingtosupportthedevelopmentofaptamerbasedanalyticalstrategies AT tomalorenzo fffbasedhighthroughputsequenceshortlistingtosupportthedevelopmentofaptamerbasedanalyticalstrategies AT giordanistefano fffbasedhighthroughputsequenceshortlistingtosupportthedevelopmentofaptamerbasedanalyticalstrategies AT rondaluca fffbasedhighthroughputsequenceshortlistingtosupportthedevelopmentofaptamerbasedanalyticalstrategies AT rodabarbara fffbasedhighthroughputsequenceshortlistingtosupportthedevelopmentofaptamerbasedanalyticalstrategies AT zattoniandrea fffbasedhighthroughputsequenceshortlistingtosupportthedevelopmentofaptamerbasedanalyticalstrategies AT reschiglianpierluigi fffbasedhighthroughputsequenceshortlistingtosupportthedevelopmentofaptamerbasedanalyticalstrategies AT carerimaria fffbasedhighthroughputsequenceshortlistingtosupportthedevelopmentofaptamerbasedanalyticalstrategies |